Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-18 Sale | 2024-01-18 8:24 pm | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 5,468 | $1.1906 | $6,510 | 5,782 (Direct) | View |
| 2024-01-18 Sale | 2024-01-18 8:23 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 5,468 | $1.1906 | $6,510 | 10,056 (Direct) | View |
| 2024-01-18 Sale | 2024-01-18 8:22 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P Chief Executive Officer | 14,580 | $1.1906 | $17,359 | 57,112 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-14 Option Award | 2024-03-15 4:19 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 250,000 | $1.6 | 978,388 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 5:18 pm | N/A 2034-01-11 | Regulus Therapeutics Inc. | RGLS | Klassen Preston President & Head of R & D | 120,000 | $0 | 120,000 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 5:16 pm | N/A 2034-01-11 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P Chief Executive Officer | 279,000 | $0 | 320,692 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 5:08 pm | N/A 2034-01-11 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 96,250 | $0 | 96,250 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 5:04 pm | N/A 2034-01-11 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 81,250 | $0 | 85,524 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:40 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:36 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | Witz Pascale Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:34 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:31 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director | 15,000 | $0 | 15,000 (Indirect) | View |
| 2023-08-10 Option Award | 2023-08-14 4:28 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:26 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | Nunn Jason Raleigh Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:24 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | Klassen Preston President & Head of R & D | 225,000 | $0 | 225,000 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:21 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | Huang Alice Shih-hou Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:19 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 375,000 | $0 | 375,000 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:17 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 1,312,500 | $0 | 1,312,500 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:13 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:12 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 393,750 | $0 | 393,750 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 4:55 pm | N/A 2033-06-12 | Regulus Therapeutics Inc. | RGLS | Witz Pascale Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 4:54 pm | N/A 2033-06-12 | Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 4:53 pm | N/A 2033-06-12 | Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director | 30,000 | $0 | 30,000 (Indirect) | View |
| 2023-06-13 Option Award | 2023-06-13 4:50 pm | N/A 2033-06-12 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 4:49 pm | N/A 2033-06-12 | Regulus Therapeutics Inc. | RGLS | Nunn Jason Raleigh Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 4:48 pm | N/A 2033-06-12 | Regulus Therapeutics Inc. | RGLS | Huang Alice Shih-hou Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 4:47 pm | N/A 2033-06-12 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 4:46 pm | N/A 2033-06-12 | Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-12 4:48 pm | N/A 2033-06-11 | Regulus Therapeutics Inc. | RGLS | Klassen Preston President & Head of R & D | 350,000 | $0 | 350,000 (Direct) | View |
| 2023-04-13 Option Award | 2023-04-14 4:39 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 222,198 | $0.9001 | 728,388 (Direct) | View |
| 2023-01-11 Option Award(A) | 2023-01-17 4:13 pm | N/A 2033-01-10 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 45,000 | $0 | 45,000 (Direct) | View |
| 2023-01-11 Option Award | 2023-01-17 4:11 pm | N/A 2033-01-10 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-01-11 Option Award | 2023-01-17 4:10 pm | N/A 2033-01-10 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2023-01-11 Option Award | 2023-01-17 4:07 pm | N/A 2033-01-10 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:24 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:21 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:19 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | Huang Alice Shih-hou Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:19 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | Nunn Jason Raleigh Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:18 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 90,000 | $0 | 90,000 (Direct) | View |